1 / 21

MEETING OF THE FEDERAL PARTNERS IN TECHNOLOGY TRANSFER (FPTT) – NATIONAL JUNE 1 ST 2005

MEETING OF THE FEDERAL PARTNERS IN TECHNOLOGY TRANSFER (FPTT) – NATIONAL JUNE 1 ST 2005. EILEEN RAYMOND – INDUSTRIAL AFFAIRS. Personnel. Employees of BRI – CNRC 262 Guest workers 163 Students 105 Company employees 393 TOTAL 2003 - 2004 925. Plant surface.

yitta
Download Presentation

MEETING OF THE FEDERAL PARTNERS IN TECHNOLOGY TRANSFER (FPTT) – NATIONAL JUNE 1 ST 2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MEETING OF THE FEDERALPARTNERS IN TECHNOLOGY TRANSFER(FPTT) – NATIONALJUNE 1ST 2005 EILEEN RAYMOND – INDUSTRIAL AFFAIRS

  2. Personnel • Employees of BRI – CNRC 262 • Guest workers 163 • Students 105 • Company employees 393 TOTAL 2003 - 2004 925 • Plant surface • 1987 19 444 m2 • 2003 (now) 31 191 m2 • BRI expenses 2003 - 2004 • Financed by BRI budget $ 20 284 M • Financed by NRC special projects $ 5 278 M • Financed by revenues generated by BRI $ 7 352 M

  3. The Biotechnology Research Institute is committed to the mission of the National Research Council in serving the needs of Canadians by helping to maintain and enhance the economic and social well-being of the country. The Biotechnology Research Institute promotes, assists and performs leading-edge research and development in biochemical engineering, molecular biology and genomics, closely linked to the needs of the industries in the pharmaceutical and environmental sectors.

  4. Director General Human Resources Building Engineer Industrial Affairs Director Finance & Administration Bioprocess Director Health Director Environment Director Macromolecular Structure Protein Chemistry Enzymology Biomolecular NMR The Receptor, Signaling and Proteomics Computational Chemistry Mammalian Cell Genetics Genetics Microbial & Enzymatic Technology Animal Cell Culture Genomics and Gene Therapy Vectors Environment Genetics Environmental Microbiology Environmental Bioengineering Analytical Chemistry Biosensors Applied Ecotoxicology Bioconversion / Sustainable Development

  5. COLLABORATIONS Distribution of active collaboration agreements in 2003-2004 • 31 new collaboration agreements • 50 active collaboration agreements • 46 canadian partners (92%)

  6. IP COMMITTEES Background 2001 • Comments 2005 • Author – • Andy Storer • Director Health Sector • NRC IPMC Meeting at BRI • First IP Committee September 1999

  7.     IP COMMITTEES Background 2001 • Comments 2005 • Bottleneck in Technology Transfer (Resources) • Need to strenghten technologies for patenting 2005 

  8. IP COMMITTEES Background 2001 • Comments 2005 • Paperwork issues at the beginning • Implemented to Bioprocess and Environment Sectors (2001) • Follow-up of actions difficult for a long time • Structure changes needed • 2004/2005 model : mature and functional

  9. IP COMMITTEES Background 2001 • Comments 2005 • No change

  10. IP COMMITTEES Background 2001 • Comments 2005 • No change

  11. IP COMMITTEES Background 2001 • Comments 2005 • Number of total presentations has dropped through the years • Number of publications maintained • More  "parcels" of research presented (gaining 6 months earlier) • Comparison checks need to be done Publications vs Presentations • Issues with principal authors outside

  12. IP COMMITTEES Background 2001 • Comments 2005 • On the spot with the right people, open discussion for screening decision (hold or publish) using simplified criteria: • 1º Patentability: new, useful, non obvious (Form 1) • 2º Some intuitive market rational • 3º Follow-up on research • If more info is needed, postpone decision to next month

  13. IP COMMITTEES Background 2001 • Comments 2005 • Duly completed Form 1 and manuscripts are assessed to ensure sufficient data is provided to support a useful scope of claims for patent applications

  14. IP COMMITTEES Background 2001 • Comments 2005 • Improvement ongoing for timeline of tasks and actions

  15. IP COMMITTEES Background 2001 • Comments 2005 • Paperwork issues • Coordination issues • Follow-up on actions issues • Marketing resources issues • For a long time still reactive mode facing deadlines

  16.    IP COMMITTEES Background 2001 • Comments 2005 • For few years, number of files increased • Number of files decreased to reach a plateau due to better selectivity • Better management for older files including dropping cases when appropriate • Knowledgeable scientists on IP issues 2005

  17. IP COMMITTEES Background 2001 • Comments 2005 • First IP Committee – September 1999 • Prior to 1999, few files • Following the growth, a switch from quantity to quality

  18. IP COMMITTEES Background 2001 • Comments 2005 • Cost control was reached in 2004 • Less files and better control (IP AUDIT) • Culture shift allows the IP integration within daily R&D work • A Patent is not something on the side for anyone! • Need to link IP Management and Project Management • Need resources for technology assessment, marketing and technology transfer 2005  

  19. Composition : • 1 Patent Agent (IPS Ottawa) • 1 IP Coordinator • 2 Business Development Officers (BDOs) • Sector Director (presides meeting) • Director of Industrial Affairs • Group leaders (3 permanents/18 months) • 1 monthly meeting in 2 parts • Scientific presentation (open to all) – PART 1 Decision on protection and/or publication • IP portfolio management – PART 2 Controlling fees and follow-ups on files, with actions of protection and marketing • Separate work-meetings for prioritary files • Valuation of technology • Strategy and actions to ensure Technology Transfer IP COMMITTEEOperation IP Committees (2004 / 2005 Model) • 1 committee per Scientific Sector • Environment, Bioprocess, Health)

  20. Business Affairs Opportunity (1 pager)

  21. Business Affairs Opportunity (1 pager)

More Related